313 related articles for article (PubMed ID: 21110820)
1. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
Mathupala SP
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
Shafaee A; Dastyar DZ; Islamian JP; Hatamian M
Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
5. Drugging cancer metabolism: Expectations vs. reality.
Montrose DC; Galluzzi L
Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
[TBL] [Abstract][Full Text] [Related]
6. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
Talekar M; Boreddy SR; Singh A; Amiji M
Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
[TBL] [Abstract][Full Text] [Related]
7. Targeting metabolic remodeling in glioblastoma multiforme.
Wolf A; Agnihotri S; Guha A
Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
[TBL] [Abstract][Full Text] [Related]
8. Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis.
Mathupala SP; Colen CB; Parajuli P; Sloan AE
J Bioenerg Biomembr; 2007 Feb; 39(1):73-7. PubMed ID: 17354062
[TBL] [Abstract][Full Text] [Related]
9. Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.
Ononye SN; Shi W; Wali VB; Aktas B; Jiang T; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2014 Dec; 148(3):477-88. PubMed ID: 25395317
[TBL] [Abstract][Full Text] [Related]
10. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of targeting cancer metabolism for cancer therapy.
Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
Sheng H; Tang W
Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
[TBL] [Abstract][Full Text] [Related]
13. Targeting metabolic dependencies in pediatric cancer.
Issaq SH; Heske CM
Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle and energy metabolism in tumor cells: strategies for drug therapy.
Amoedo ND; El-Bacha T; Rodrigues MF; Rumjanek FD
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):15-25. PubMed ID: 21110821
[TBL] [Abstract][Full Text] [Related]
16. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
17. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
18. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
20. An Update on Patents Covering Agents That Interfere with the Cancer Glycolytic Cascade.
Fortunato S; Bononi G; Granchi C; Minutolo F
ChemMedChem; 2018 Nov; 13(21):2251-2265. PubMed ID: 30226288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]